QORVO INC
QRVONASDAQ🏆 #911 by market capEarnings Nov 2US Equity
$98.74▲ $0.50 (+0.51%)
Live1h▲ 0.3%
24h▲ 0.5%
7d▲ 3.6%
14d▲ 8.8%
30d▲ 19.7%
1y▲ 9.6%
🏦Market Cap
$8.71B
Small Cap
📈Revenue Growth (YoY)
-0.2%
Declining
📊Gross Margin
48.5%
Healthy
💵FCF Margin
17.8%
Healthy
⚖️P/S Ratio
2.4x
Cheap
Otter Score
60
Fair
📊
Analyst Ratings
Price
$98.74
Total
42
Raised
6
Lowered
14
Avg PT
$94.00
H / L
$120 / $66
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Citigroup | Reiterated | Neutral | 2026-07-29 | $113.00 | +14.40% |
UBS | Reiterated | Neutral | 2026-07-29 | $96.00 | −2.80% |
JP Morgan | Reiterated | Neutral | 2026-05-06 | $90.00 | −8.90% |
Barclays | Upgraded | Equal Weight → Overweight | 2026-04-22 | $60.00 | −39.20% |
Mizuho | Downgraded | Neutral → Underperform | 2026-04-20 | — | — |
Wolfe Research | Downgraded | Outperform → Peer Perform | 2026-04-17 | $120.00 | +21.50% |
Benchmark | Reiterated | Hold | 2026-01-28 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-01-28 | $90.00 | −8.90% |
Stifel | Reiterated | Hold | 2026-01-28 | — | — |
Susquehanna | Reiterated | Neutral | 2026-01-22 | $90.00 | −8.90% |
Loop Capital | Reiterated | Hold | 2025-07-30 | — | — |
Needham | Reiterated | Buy | 2025-07-30 | $125.00 | +26.60% |
Morgan Stanley | Upgraded | Equal Weight → Overweight | 2025-01-21 | $84.00 | −14.90% |
Goldman Sachs | Reiterated | Neutral | 2025-01-10 | $99.00 | +0.30% |
TD Cowen | Reiterated | Hold | 2024-10-30 | — | — |
Raymond James | Downgraded | Outperform → Market Perform | 2024-10-30 | $100.00 | +1.30% |
B of A Securities | Reiterated | Underperform | 2024-10-30 | — | — |
Craig-Hallum | Reiterated | Buy | 2024-10-30 | $120.00 | +21.50% |
Exane BNP Paribas | Downgraded | Outperform → Neutral | 2024-10-30 | — | — |
Rosenblatt | Reiterated | Neutral | 2024-07-31 | — | — |
BMO Capital | Reiterated | Market Perform | 2023-11-03 | $105.00 | +6.30% |
Summit Insights Group | Downgraded | Buy → Hold | 2023-11-02 | — | — |
Wells Fargo | Reiterated | Equal Weight | 2023-08-03 | $110.00 | +11.40% |
Cowen & Co. | Reiterated | Market Perform | 2023-02-02 | $100.00 | +1.30% |
KGI Securities | Downgraded | Outperform → Neutral | 2022-04-01 | — | — |
Oppenheimer | Downgraded | Outperform → Perform | 2022-01-13 | — | — |
Argus Research | Downgraded | Buy → Hold | 2021-11-05 | — | — |
CFRA | Reiterated | Hold | 2020-05-08 | $122.00 | +23.60% |
Canaccord Genuity | Reiterated | Buy | 2020-04-14 | — | — |
Bank of America | Upgraded | Underperform → Buy | 2019-12-09 | — | — |
Keybanc | Downgraded | Overweight → Sector Weight | 2019-04-26 | — | — |
KeyBanc | Downgraded | Overweight → Sector Weight | 2019-04-26 | — | — |
MKM Partners | Reiterated | Buy | 2018-11-14 | — | — |
Nomura | Reiterated | Neutral | 2018-11-14 | — | — |
Instinet | Downgraded | Buy → Neutral | 2018-03-20 | — | — |
Nomura Instinet | Downgraded | Buy → Neutral | 2018-03-20 | — | — |
Northland Securities | Upgraded | Market Perform → Outperform | 2018-02-01 | — | — |
Northland Capital Markets | Upgraded | Market Perform → Outperform | 2018-02-01 | — | — |
DA Davidson | Downgraded | Buy → Neutral | 2017-05-04 | — | — |
Charter Equity | Upgraded | Market Perform → Buy | 2017-03-15 | — | — |
Brean Capital | Reiterated | Buy | 2016-05-05 | — | — |
Pacific Crest | Downgraded | Overweight → Sector Perform | 2015-09-28 | — | — |
Institution
Citigroup
Reiterated · Neutral · 2026-07-29
$113.00
+14.40%
UBS
Reiterated · Neutral · 2026-07-29
$96.00
−2.80%
JP Morgan
Reiterated · Neutral · 2026-05-06
$90.00
−8.90%
Barclays
Upgraded · Equal Weight → Overweight · 2026-04-22
$60.00
−39.20%
Mizuho
Downgraded · Neutral → Underperform · 2026-04-20
—
—
Wolfe Research
Downgraded · Outperform → Peer Perform · 2026-04-17
$120.00
+21.50%
Benchmark
Reiterated · Hold · 2026-01-28
—
—
Piper Sandler
Reiterated · Overweight · 2026-01-28
$90.00
−8.90%
Stifel
Reiterated · Hold · 2026-01-28
—
—
Susquehanna
Reiterated · Neutral · 2026-01-22
$90.00
−8.90%
Loop Capital
Reiterated · Hold · 2025-07-30
—
—
Needham
Reiterated · Buy · 2025-07-30
$125.00
+26.60%
Morgan Stanley
Upgraded · Equal Weight → Overweight · 2025-01-21
$84.00
−14.90%
Goldman Sachs
Reiterated · Neutral · 2025-01-10
$99.00
+0.30%
TD Cowen
Reiterated · Hold · 2024-10-30
—
—
Raymond James
Downgraded · Outperform → Market Perform · 2024-10-30
$100.00
+1.30%
B of A Securities
Reiterated · Underperform · 2024-10-30
—
—
Craig-Hallum
Reiterated · Buy · 2024-10-30
$120.00
+21.50%
Exane BNP Paribas
Downgraded · Outperform → Neutral · 2024-10-30
—
—
Rosenblatt
Reiterated · Neutral · 2024-07-31
—
—
BMO Capital
Reiterated · Market Perform · 2023-11-03
$105.00
+6.30%
Summit Insights Group
Downgraded · Buy → Hold · 2023-11-02
—
—
Wells Fargo
Reiterated · Equal Weight · 2023-08-03
$110.00
+11.40%
Cowen & Co.
Reiterated · Market Perform · 2023-02-02
$100.00
+1.30%
KGI Securities
Downgraded · Outperform → Neutral · 2022-04-01
—
—
Oppenheimer
Downgraded · Outperform → Perform · 2022-01-13
—
—
Argus Research
Downgraded · Buy → Hold · 2021-11-05
—
—
CFRA
Reiterated · Hold · 2020-05-08
$122.00
+23.60%
Canaccord Genuity
Reiterated · Buy · 2020-04-14
—
—
Bank of America
Upgraded · Underperform → Buy · 2019-12-09
—
—
Keybanc
Downgraded · Overweight → Sector Weight · 2019-04-26
—
—
KeyBanc
Downgraded · Overweight → Sector Weight · 2019-04-26
—
—
MKM Partners
Reiterated · Buy · 2018-11-14
—
—
Nomura
Reiterated · Neutral · 2018-11-14
—
—
Instinet
Downgraded · Buy → Neutral · 2018-03-20
—
—
Nomura Instinet
Downgraded · Buy → Neutral · 2018-03-20
—
—
Northland Securities
Upgraded · Market Perform → Outperform · 2018-02-01
—
—
Northland Capital Markets
Upgraded · Market Perform → Outperform · 2018-02-01
—
—
DA Davidson
Downgraded · Buy → Neutral · 2017-05-04
—
—
Charter Equity
Upgraded · Market Perform → Buy · 2017-03-15
—
—
Brean Capital
Reiterated · Buy · 2016-05-05
—
—
Pacific Crest
Downgraded · Overweight → Sector Perform · 2015-09-28
—
—
One row per institution · price target from the firm's latest published target